Gilles Guillemette
CIK: 0002131206
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ICCC
IMMUCELL CORP /DE/
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Guillemette Gilles
Guillemette Gilles (SEC CIK 0002131206) files insider reports with the SEC as Director of IMMUCELL CORP /DE/ (ICCC).
Signal8 holds 1 ownership filing by Guillemette Gilles, a Form 3, filed on Apr 23, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Guillemette Gilles's filings is in PORTLAND, ME.
Other insiders filing for IMMUCELL CORP /DE/ (ICCC)
- te Boekhorst Paul Francis Olivier, President and CEO
- DiMarco Anthony, Director
- Turner Kathy V, Director
- Tomsche David Scott, Director
- Basse Gloria F, Director
- Wainman Paul R, Director